Widely used:Recently Viewed
Clear All$0.57
$-0.01
(-2.17%)
As on 21-Apr-2025 16:09EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$27 Mln
P/E Ratio
--
P/B Ratio
9.36
Industry P/E
82.47
Debt to Equity
0
ROE
-1.96 %
ROCE
--
Div. Yield
0 %
Book Value
--
EPS
-0.28
CFO
$-40.04 Mln
EBITDA
$-45.33 Mln
Net Profit
$-57.46 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Neuroone Medical Technologies Corp (NMTC)
| -31.35 | -43.30 | -46.00 | -50.70 | -18.23 | -36.97 | -- |
|
BSE Sensex*
| 1.83 | 3.60 | 5.06 | 9.01 | 11.22 | 21.06 | 11.15 |
|
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|
|---|---|---|---|---|---|---|
|
Neuroone Medical Technologies Corp (NMTC)
| -47.45 | 31.67 | -38.14 | 23.57 | -34.03 | -57.19 |
|
S&P Small-Cap 600
| 7.01 | 13.89 | -17.42 | 25.27 | 9.57 | 20.86 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | P/E Ratio | ROE |
|---|---|---|---|---|
| 14.96 | 10,289.47 | 14.52 | 12.69 | |
| 69.39 | 9,766.86 | 94.68 | 2.52 | |
| 149.24 | 8,221.46 | -- | -25.23 | |
| 270.64 | 10,728.92 | 770.42 | 1.2 |
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for... spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota. Address: 7599 Anagram Drive, Eden Prairie, MN, United States, 55344 Read more
President, CEO & Director
Mr. David A. Rosa M.D.
President, CEO & Director
Mr. David A. Rosa M.D.
Headquarters
Eden Prairie, MN
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Neuroone Medical Technologies Corp (NMTC) stood at $ 8 Mln as on 31-Dec-24
The share price of Neuroone Medical Technologies Corp (NMTC) is $0.57 (NASDAQ) as of 21-Apr-2025 16:09 EDT. Neuroone Medical Technologies Corp (NMTC) has given a return of -18.23% in the last 3 years.
Neuroone Medical Technologies Corp (NMTC) has a market capitalisation of $ 27 Mln as on 21-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Neuroone Medical Technologies Corp (NMTC) is 9.36 times as on 21-Apr-2025, a 187% premium to its peers’ median range of 3.26 times.
Since, TTM earnings of Neuroone Medical Technologies Corp (NMTC) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Neuroone Medical Technologies Corp (NMTC) and enter the required number of quantities and click on buy to purchase the shares of Neuroone Medical Technologies Corp (NMTC).
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, radio frequency and brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company also focuses on applications of its technology associated with artificial intelligence. It has partnership with RBC Medical Innovations to develop a radio frequency ablation generator. NeuroOne Medical Technologies Corporation is based in Eden Prairie, Minnesota. Address: 7599 Anagram Drive, Eden Prairie, MN, United States, 55344
The CEO & director of Mr. David A. Rosa M.D.. is Neuroone Medical Technologies Corp (NMTC), and CFO & Sr. VP is Mr. David A. Rosa M.D..
There is no promoter pledging in Neuroone Medical Technologies Corp (NMTC).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,070
|
|
|
1,049
|
|
|
978
|
|
|
820
|
| Neuroone Medical Technologies Corp (NMTC) | Ratios |
|---|---|
|
Return on equity(%)
|
-241.73
|
|
Operating margin(%)
|
-110.3
|
|
Net Margin(%)
|
-125.02
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Neuroone Medical Technologies Corp (NMTC) was $0 Mln.
